On Monday, November 16, 2020, the Company, Titan Pharmaceuticals, Inc., TTNP stock construct a change of -1.11 percent (Loss) in a total of its share price and having its trading value $0.12, which belongs to Healthcare sector and Biotechnology industry. The company?s Market capitalization was $22.26M with the total Outstanding Shares of 196.76M.
P/S, P/E, P/B & P/C values of (NASDAQ: TTNP):
Titan Pharmaceuticals, Inc. institutional ownership is standing at 6.2 percent, while insider ownership is 5.08 percent. As of now, TTNP has a P/S, P/E and, P/B values of 4.64, 0, and 5.81 respectively. Its P/Cash is valued at 4.05.
The stock SMA50 is now at -25.35 percent. In looking, the SMA 200 we see that the stock has seen a -52.67 percent. The Company?s net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 76.4 percent.
Profitability ratios:
Looking into the profitability ratios of TTNP stock, an investor will find its ROE, ROA, ROI standing at 0 percent, -179.3 percent and, -307.7 percent, respectively.
Beta Factor:
A beta factor is used to measure the volatility of the stock. The stock remaining at 18.81 percent volatile for the week and 16.64 percent for the month.
Gross / Operating Margins of TTNP:
It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 76.4 percent & Operating Margin seen at 0 percent.
Target Price:
Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Titan Pharmaceuticals, Inc. recorded it at $0.
Historical Performance In The News:
Taking a look at the performance of Titan Pharmaceuticals, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at 9.83 percent, resulting in a performance for the month at -18.46 percent.
Therefore, the stated figure displays a quarterly performance of -57.67 percent, bringing six-month performance to -55.98 percent and year to date performance of -40.13 percent. As of now, Titan Pharmaceuticals, Inc. has a P/S, P/E and, P/B values of 4.64, 0, and 5.81 respectively. Its P/Cash is valued at 4.05.
Earnings per Share Details of Titan Pharmaceuticals, Inc.:
The EPS of TTNP is strolling at -0.38, measuring its EPS growth this year at 7.9 percent. As a result, the company has an EPS growth of 12.5 percent for the approaching year.
